TET2 mutations occur in over 20% of adults with de novo cytogenetically normal AML, and their prevalence increases with age: A Cancer and Leukemia Goup B study.
- Citation:
- Haematologica vol 95 (Supplement)
- Meeting Instance:
- EHA 2010
- Year:
- 2010
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- 192
- Program:
- TRP
- Primary Committee:
- Leuk Corr Sci
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- K. H. Metzeler K. Maharry D. Margeson J. Curfman H. Becker M. D. Radmacher K. Mrózek K. Holland S. P. Whitman Y.-Z. Wu S. Schwind W. Blum B. L. Powell T. H. Carter M. R. Baer A. J. Carroll J. O. Moore J. E. Kolitz R. A. Larson M. A. Caligiuri G. Marcucci C. D. Bloomfield
- Networks:
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-8525, CALGB-10201, CALGB-19808, CALGB-20202, CALGB-20502, CALGB-8461, CALGB-8923, CALGB-9420, CALGB-9621, CALGB-9665, CALGB-9720
- Phases:
- 1, 3, N/A
- Keywords: